Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001753926-25-001541
Filing Date
2025-09-19
Accepted
2025-09-19 16:31:25
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3/A g084947_s3a.htm S-3/A 93153
2 EXHIBIT 23.1 g084947_ex23-1.htm EX-23.1 4063
3 EXHIBIT 23.3 g084947_ex23-3.htm EX-23.3 2404
4 EXHIBIT 23.4 g084947_ex23-4.htm EX-23.4 2190
  Complete submission text file 0001753926-25-001541.txt   103071
Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-289916 | Film No.: 251327242
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)